Let’s Meet the Virologists

We talk with Dr. Hinissan Pascaline Kohio, a postdoctoral research associate in the Ding lab at Washington University School of Medicine in St. Louis about her work studying rotavirus, an enteric pathogen in young children.

We talk with Dr. Adam Bailey, a clinical pathology fellow, and Sasha Dmytrenko, an MSTP student, about their work investigating extra-pulmonary effects of COVID-19, specifically on the heart.

We talk with Dr. Sharmila Nair, a staff scientist, about her work investigating how Zika virus might be used to target a fatal human cancer, Glioblastoma multiforme.

We talk with Dr. Tristan Jordan, a postdoctoral scholar, about his work using a CRISPR screen and proteomics of the viral replication complex to identity potential drug targets for SARS-CoV-2.

We talk with Dr. Rachel Presti, an associate professor, about her work with clinical trials to examine how well different drugs, therapies, and vaccines work to prevent and treat COVID-19.

We talk with Dr. Brett Case, a postdoctoral researcher, about his work identifying and characterizing numerous monoclonal antibodies against SARS-CoV-2.

We talk with Dr. Sigrid Gouma, a postdoctoral researcher, who has been examining antibody responses during SARS-CoV-2 infection to determine the impact of COVID-19 on specific populations such as pregnant women and to prevent transmission from those with asymptomatic infection.

We talk with Dr. Ben Israelow, an infectious diseases fellow, about his work using small animal models and human patient samples to determine why some patients recover from COVID-19 while others do not.

We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.

We talk with Dr. David Martinez, a postdoctoral researcher, about his work evaluating therapies and vaccines against SARS-CoV-2.